|
|
|
Volumn 21, Issue 126, 2012, Pages 106-110
|
|
New drugs and indications in 2011. France is better focused on patients' interests after the Mediator° scandal, but stagnation elsewhere
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACICLOVIR PLUS HYDROCORTISONE;
AMIFAMPRIDINE (3,4 DIAMINOPYRIDINE);
AMLODIPINE PLUS TELMISARTAN;
BECAPLERMIN;
BOSENTAN;
BUFLOMEDIL;
CELECOXIB;
CLORAZEPATE;
COMPLEMENT COMPONENT C1S INHIBITOR;
CORIFOLLITROPIN ALFA;
DENOSUMAB;
DEXTROPROPOXYPHENE;
DOCETAXEL;
DRONEDARONE;
DUTASTERIDE PLUS TAMSULOSIN;
ESLICARBAZEPINE;
FENTANYL;
HISTRELIN;
KETOCONAZOLE;
LOSARTAN;
MESALAZINE;
NEW DRUG;
NIMESULIDE;
PHOLCODINE;
PRUCALOPRIDE;
TOCOFERSOLAN;
TRIMETAZIDINE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VARDENAFIL;
VELAGLUCERASE ALFA;
DRUG;
ANGINA PECTORIS;
ANGIONEUROTIC EDEMA;
BREAST CANCER;
CANCER PAIN;
CHILDHOOD DISEASE;
CONSTIPATION;
DIZZINESS;
DRUG INDICATION;
DRUG INDUSTRY;
DRUG LEGISLATION;
DRUG MARKETING;
EATON LAMBERT SYNDROME;
ENTERITIS;
ERECTILE DYSFUNCTION;
FOCAL EPILEPSY;
FRAGILITY FRACTURE;
FRANCE;
GAUCHER DISEASE;
HERPES LABIALIS;
HUMAN;
HYPERTENSION;
LIVER INJURY;
PAIN;
PROSTATE CANCER;
PROSTATE HYPERTROPHY;
PULMONARY HYPERTENSION;
SELF MEDICATION;
SHORT SURVEY;
TINNITUS;
UNSPECIFIED SIDE EFFECT;
VISUAL DISORDER;
ARTICLE;
DRUG APPROVAL;
DRUG RECALL;
LEGAL ASPECT;
STANDARD;
DRUG APPROVAL;
DRUG INDUSTRY;
FRANCE;
HUMANS;
LEGISLATION, DRUG;
PHARMACEUTICAL PREPARATIONS;
SAFETY-BASED DRUG WITHDRAWALS;
|
|
EID: 84860601267
PISSN: 11677422
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (12)
|
|
References (0)
|